Cite
HARVARD Citation
Sator, P. et al. (n.d.). Adalimumab in the treatment of moderate‐to‐severe chronic plaque psoriasis in patients switching from other biologics. Journal of the European Academy of Dermatology and Venereology. pp. 1742-1749. [Online].